Clinical Trials · NCT01492972
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Proton Collaborative Group
- Enrollment
- 192
- Start date
- Jan 2012
- Locations
- 4 sites, United States
- Primary endpoint
- Morbidity Outcomes